Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 5:17 PM
Ignite Modification Date: 2025-12-24 @ 5:17 PM
NCT ID: NCT03270150
Eligibility Criteria: Inclusion Criteria: * Age ≥ 21 years * Voluntarily signed informed consent form * BMI ≤ 35 kg/m2 * Women of child-bearing potential are required to use birth control measures during the whole duration of the study * Subjects willing and able to abstain from partaking in any treatments other than the study procedure to promote body contouring during study participation * Subjects willing and able to maintain his/her regular (pre-procedure) diet and exercise regimen without effecting significant change in either direction during study participation Exclusion Criteria: * Cardiac pacemakers * Cardiovascular diseases * Implanted defibrillators, implanted neurostimulators * Electronic implants * Disturbance of temperature or pain perception * Pulmonary insufficiency * Metal implants * Drug pumps * Malignant tumor * Hemorrhagic conditions * Septic conditions and empyema * Acute inflammations * Systemic or local infection such as osteomyelitis and tuberculosis * Contageous skin disease * Elevated body temperature * Pregnancy * Breastfeeding * Injured or otherwise impaired muscles * Scars, open lesions and wounds at the treatment area * Basedow's disease * Previous liposuction in the treatment area in the last six months * Abdominal wall diastasis * Unstable weight within the last 6 months * Previous body contouring treatments in the abdomen area in the last three months
Healthy Volunteers: True
Sex: ALL
Minimum Age: 22 Years
Study: NCT03270150
Study Brief:
Protocol Section: NCT03270150